HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Picks Up CeraVe Skin Care Via $1.3bn Deal With Valeant

This article was originally published in The Rose Sheet

Executive Summary

The CeraVe, AcneFree and Ambi skin-care lines will change hands from Valeant Pharmaceuticals to L’Oreal under a deal announced Jan. 10, beefing up the latter’s dermatologist-aligned Active Cosmetics division.

You may also be interested in...



As L’Oréal Sales Grow At Twice Beauty Market Rate, CEO Expects Inflation Won't Slow Consumers

L’Oréal reports CeraVe skin care sales up more than 40% year-to-date as it expands brand within US as well as in regions where it’s newly launched. French firm reported July-September sales rose 9.1% on a like-for-like basis.

Consumer Health Brands Should Increase Value As Higher Prices Discourage Consumers – IRI

At CHPA conference, IRI's lead for health care market data, Kristin Hornberger, said as manufacturers increase product prices in response to rising costs and inflationary pressures, they also should work to make their products more valuable to consumers.

L'Oreal Vows Consumer Division Excitement; 'Mass Will Be Back,' CEO Says

L'Oreal Luxe's 10.5% like-for-like growth in fiscal 2017 substantially overshadowed the 2.2% LFL improvement in the firm's Consumer Products unit. "Maybe in the mass [channel] in the U.S. for the past two or three years, we didn't give consumers enough desire to want to buy beauty," but the company is committed to accelerating innovation and bringing consumers back, CEO Jean-Paul Agon says

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS109013

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel